Clinical experiences with nimodipine treatment in patients after SAH and aneurysm surgery.
The authors present their 3-years experiences with nimodipine treatment in patient after subarachnoid haemorrhage (SAH). Nimotop has been used in treatment of SAH in the Department of Neurosurgery since June 1985. During 3-years 220 patients with subarachnoid haemorrhage were admitted to the Department of Neurosurgery in Wroclaw. Till the end of 1989 177 patients with SAH received nimotop therapy. Our results show that intravenous Nimodipine is well tolerated, and we have not observed any discontinuation effects, after we had introduced gradual diminishing doses of Nimotop. Nimotop does not prevent of developing vasospasm in all patients, but their outcome is better. The treatment of vasospasm should be complex (with nimotop and hypervolemic and hypertensive therapy).
Wroński
J
J
Department of Neurosurgery, Academy of Medicine in Wroclaw.
Abraszko
R
R
Berny
W
W
Mierzwa
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D002532:Intracranial Aneurysm / Q000601:surgery*; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009553:Nimodipine / Q000008:administration & dosage* / Q000009:adverse effects; D011183:Postoperative Complications / Q000188:drug therapy*; D011292:Premedication; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy* / Q000601:surgery
D009553:Nimodipine